<DOC DOCNO="nw/wsj/20/wsj_2089@2089@wsj@nw@en@on">
<ENAMEX TYPE="ORG">Sandoz AG</ENAMEX> , a major <ENAMEX TYPE="NORP">Swiss</ENAMEX> chemical and pharmaceutical group , said that its group sales rose <ENAMEX TYPE="PERCENT">25 %</ENAMEX> to <ENAMEX TYPE="MONEY">9.482 billion francs</ENAMEX> -LRB- <ENAMEX TYPE="MONEY">$ 5.80 billion</ENAMEX> -RRB- in <ENAMEX TYPE="DATE">the first nine months of this year</ENAMEX> , with strong gains in all divisions .
<ENAMEX TYPE="DATE">A year earlier</ENAMEX> sales totaled <ENAMEX TYPE="MONEY">7.567 billion francs</ENAMEX> .
Positive currency rates and strong sales growth led to a substantial rise in consolidated profit in the period , although the company did n't provide figures , as is customary with <ENAMEX TYPE="NORP">Swiss</ENAMEX> companies .
<ENAMEX TYPE="ORG">Sandoz</ENAMEX> said it expects a `` substantial increase '' in consolidated profit for <ENAMEX TYPE="DATE">the full year</ENAMEX> , barring major currency rate changes .
</DOC>
